The Valley Desk

NCT02785913 · Interventional trial

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Overall registry status Completed

Phase 2

Conditions Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov